BioLife Solutions BLFS Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's allowance for doubtful accounts receivable (current)?
- BioLife Solutions (BLFS) reported allowance for doubtful accounts receivable (current) of $27K in Q1 2026.
- How has BioLife Solutions's allowance for doubtful accounts receivable (current) changed year-over-year?
- BioLife Solutions's allowance for doubtful accounts receivable (current) decreased by 76.9% year-over-year, from $117K to $27K.
- What is the long-term trend for BioLife Solutions's allowance for doubtful accounts receivable (current)?
- Over 3 years (2022 to 2025), BioLife Solutions's allowance for doubtful accounts receivable (current) has grown at a -69.0% compound annual growth rate (CAGR), from $739K to $22K.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.